Publisher
Springer International Publishing
Reference610 articles.
1. Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., Wang, Y. T., Salter, M. W., & Tymianski, M. (2002). Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science, 298, 846–850.
2. Acar, H., Ting, J. M., Srivastava, S., Labelle, J. L., & Tirrell, M. V. (2017). Molecular engineering solutions for therapeutic peptide delivery. Chemical Society Reviews, 46, 6553–6569.
3. Adhikari, S., Alahmadi, T. I., Gong, Z., & Karlsson, A. J. (2018). Expression of cell-penetrating peptides fused to protein cargo. Journal of Molecular Microbiology and Biotechnology, 28, 159–168.
4. Ahmed, C. M., Massengill, M. T., Brown, E. E., Ildefonso, C. J., Johnson, H. M., & Lewin, A. S. (2018). A cell penetrating peptide from SOCS-1 prevents ocular damage in experimental autoimmune uveitis. Experimental Eye Research, 177, 12–22.
5. Ahmed, C. M., Patel, A. P., Ildefonso, C. J., Johnson, H. M., & Lewin, A. S. (2021). Corneal application of R9-SOCS1-KIR peptide alleviates endotoxin-induced uveitis. Translational Vision Science & Technology, 10, 25.